Nuzenio

Xdemvy

Xdemvy news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Timeline

Sun, 09 Aug 2026 08:50:32 GMTWhy Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising XDEMVY 2026 Sales Guidance And Acquiring Alkeus - simplywall.st
Sat, 08 Aug 2026 01:11:15 GMTTarsus Pharmaceuticals (TARS) Stock Can Revenue Momentum Outrun Rising Costs - simplywall.st
Fri, 07 Aug 2026 00:02:00 GMTTarsus Pharmaceuticals 2026 Q2 Results: XDEMVY Sales, Risks, and Key Financials Revealed - Minichart
Thu, 06 Aug 2026 19:02:11 GMTTarsus Pharmaceuticals Inc (TARS) (Q2 2026) Earnings Call Highlights: Record XDEMVY Sales and ... - Yahoo Finance
Thu, 06 Aug 2026 18:00:39 GMTTarsus Pharmaceuticals Raises 2026 XDEMVY Net Pdt Sales Guidance to $685M-$705M >TARS - Moomoo
Thu, 06 Aug 2026 11:36:49 GMTTarsus Pharmaceuticals Q2 sales beat estimates, lifts 2026 XDEMVY sales outlook - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Xdemvy.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.